Author: Shafran, Noa; Issachar, Assaf; Shochat, Tzippy; Shafran, Inbal Haya; Bursztyn, Michael; Shlomai, Amir
Title: Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities Cord-id: 0b9oqy5m Document date: 2021_2_24
ID: 0b9oqy5m
Snippet: BACKGROUND & AIMS: Abnormal liver tests are common in patients with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with short-term outcomes are controversial. Therefore, we aimed to compare the pattern of abnormal liver tests in SARS-CoV-2 patients with those of patients infected with influenza, a non-hepatotropic respiratory virus, and their association with worse outcomes during hospitalizatio
Document: BACKGROUND & AIMS: Abnormal liver tests are common in patients with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection, but a possible direct role of the virus in liver injury and its association with short-term outcomes are controversial. Therefore, we aimed to compare the pattern of abnormal liver tests in SARS-CoV-2 patients with those of patients infected with influenza, a non-hepatotropic respiratory virus, and their association with worse outcomes during hospitalization. METHODS: A retrospective cohort study of 1737 hospitalized patients (865 with influenza and 872 with SARS-Cov-2) in a tertiary medical center. We defined abnormal liver tests as GPT or GOT ≥40IU/ML at any time-point during hospitalization. RESULTS: Abnormal liver tests were mild-moderate in the majority of patients regardless of infection type, but the majority of patients with influenza had a transaminases peak earlier during hospitalization compared to patients with SARS-Cov-2. Abnormal liver tests correlated with markers of severe disease in either influenza or SARS-Cov-2 infections, and were associated with death, occurring mainly in patients with severe liver tests abnormalities (>200IU/L) (38.7% and 60% of patients with influenza or SARS-Cov-2, respectively). In multivariate analysis, controlling for age, gender, lymphopenia and CRP, liver tests abnormalities remained significantly associated with death for influenza (OR= 4.344, 95% CI 2.218-8.508) and SARS-Cov-2 (OR= 3.898, 95% CI 2.203-6.896). These results were confirmed upon propensity score matching. CONCLUSIONS: Abnormal liver tests during hospitalization with SARS-Cov-2 or influenza infections are common, may differ in their time-course and reflect disease severity. They are associated with worse outcomes, mainly in patients with severe liver test abnormalities, regardless of infection type.
Search related documents:
Co phrase search for related documents- abnormal liver test and acute disease: 1, 2
- abnormal value and acute disease: 1
Co phrase search for related documents, hyperlinks ordered by date